InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
5,751.13
(
0.97%
)
US TECH 100
19,538.80
(
-0.17%
)
Dow Jones
42,080.37
(
0.30%
)
Brent Oil
76.88
(
-0.61%
)
Bitcoin
62,056.82
(
-0.12%
)
Post# of 20775
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

john1045

Send PM Follow Ignore
Followers 36
Posts 2689
Boards Moderated 0
Alias Born 06/09/2011

john1045

Re: montanus post# 11442

Friday, 12/27/2013 9:44:54 AM

Friday, December 27, 2013 9:44:54 AM

Post# of 20775
Nice post montanus and love the nice reference to ILNS!

Interesting candidates in ViroPharma's pipeline include maribavir for cytomegalovirus (CMV) infection and VP20629 for the treatment of Friedreich's Ataxia (FA). ViroPharma acquired VP20629 from Intellect Neurosciences, Inc. in Sep 2011.
ViroPharma generated revenues of $427.9 million in 2012.

Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next
Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up